
浏览全部资源
扫码关注微信
江西中医药大学 现代中药制剂教育部重点实验室,实验动物科技中心,南昌 330004
陈绪龙,在读博士,主管药师,从事中药新剂型与新技术研究,E-mail:cxl_0517@163.com
蒋且英,副教授,从事中药制剂应用基础研究,Tel:0791-87119190,E-mail:jxxyjqy@163.com
廖正根,博士,教授,从事中药新剂型与新技术研究,Tel:0791-87119011,E-mail:lyzlyg@163.com
收稿日期:2020-04-19,
网络出版日期:2020-06-24,
纸质出版日期:2021-01-05
移动端阅览
陈绪龙,梁新丽,刘欢等.不同载药量姜黄素自纳米乳体外分散后相行为与稳定性的相关性考察[J].中国实验方剂学杂志,2021,27(01):154-161.
CHEN Xu-long,LIANG Xin-li,LIU Huan,et al.Investigation on Correlation of Phase Behavior and Stability of Curcumin Self-nanoemulsion with Different Drug Loading After in Vitro Dispersion[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(01):154-161.
陈绪龙,梁新丽,刘欢等.不同载药量姜黄素自纳米乳体外分散后相行为与稳定性的相关性考察[J].中国实验方剂学杂志,2021,27(01):154-161. DOI: 10.13422/j.cnki.syfjx.20201949.
CHEN Xu-long,LIANG Xin-li,LIU Huan,et al.Investigation on Correlation of Phase Behavior and Stability of Curcumin Self-nanoemulsion with Different Drug Loading After in Vitro Dispersion[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(01):154-161. DOI: 10.13422/j.cnki.syfjx.20201949.
目的
2
研究不同载药量姜黄素自纳米乳(CUR-SNEDDS)在人工胃肠液中分散相行为与纳米乳稳定性的关系。
方法
2
以CUR过饱和度-时间曲线的变化趋势表示CUR- SNEDDS分散后沉淀生长速度,分别采用紫外-可见光谱法和偏振光显微镜考察载药量对晶体成核与生长的影响,利用X射线粉末衍射(XRD)和差示扫描量热法(DSC)分析不同载药量CUR-SNEDDS在人工胃肠液中沉淀存在形式,同时考察载药量对CUR-SNEDDS在人工胃肠液中形成的纳米乳稳定性的影响。
结果
2
在人工胃肠液中,随着载药量的提高,CUR过饱和度-时间曲线下面积越大(100%载药量≈90%载药量>75%载药量),结晶成核与生长速度加快(100%载药量>90%载药量>75%载药量),沉淀组成中无定型比例减小,分散后形成的纳米乳滴黏连且分布不均匀、粒径与分散性增大。
结论
2
高载药量促进了晶体成核与生长,增大了沉淀组成中晶型比例,从而导致形成的纳米乳稳定性下降,建议CUR-SNEDDS载药量控制在90%以下。
Objective
2
To investigate the relationship between phase behavior of curcumin (CUR) from self-nanoemulsion drug delivery system (SNEDDS) and stability of the formed nanoemulsion in artificial gastrointestinal fluid.
Method
2
The growth rate of precipitation after dispersion of CUR-SNEDDS was expressed by the change tendency of CUR supersaturation-time curve. The effect of drug loading on crystal nucleation and growth was investigated by ultraviolet-visible spectrometry and polarized light microscope, respectively. X-ray powder diffraction (XRD) and differential scanning calorimetry (DSC) were used to analyze the precipitation forms of CUR-SNEDDS with different drug loading in artificial gastrointestinal fluid. At the same time, the effect of drug loading on the quality stability of nanoemulsion formed by CUR-SNEDDS in artificial gastrointestinal fluid was investigated.
Result
2
In the artificial gastrointestinal fluid, with the increase of drug loading, the area under the supersaturation-time curve of CUR was increased (100% drug loading≈90% drug loading>75% drug loading), the crystallization nucleation and growth rate were accelerated (100% drug loading>90% drug loading>75% drug loading), the amorphous proportion in the precipitation composition decreased, the nanoemulsion droplets adhered and distributed unevenly, the particle size and dispersivity were increased.
Conclusion
2
High drug loading promotes the nucleation and growth of crystals, and increases the proportion of crystal forms in the precipitation composition, which leads to the decrease in the stability of the formed nanoemulsion. Therefore, it is suggested that the drug loading of CUR-SNEDDS needs to be controlled below 90%.
FEENEY O M , CRUM M F , MCEVOY C L , et al . 50 Years of oral lipid-based formulations:provenance,progress and future perspectives [J]. Adv Drug Deliv Rev , 2016 , 101 : 167 - 194 .
刘调调 , 杨白雪 , 郭瑛玉 , 等 . 表面活性剂的复配对姜黄素的增溶及保护作用 [J]. 药学学报 , 2019 , 54 ( 1 ): 8 - 13 .
KUMAR A , KAUR G , KANSAL S K , et al . Enhanced solubilization of curcumin in mixed surfactant vesicles [J]. Food Chem , 2016 , 199 : 660 - 666 .
PAN M H , HUANG T M , LIN J K . Biotransformation of curcumin through reduction and glucuronidation in mice [J]. Drug Metab Dispos , 1999 , 27 ( 4 ): 486 - 494 .
YALLAPU M M , JAGGI M , CHAUHAN S C . Curcumin nanoformulations:a future nanomedicine for cancer [J]. Drug Discov Today , 2012 , 17 ( 1/2 ): 71 - 80 .
YALLAPU M M , OTHMAN S F , CURIIS E T , et al . Curcumin-loaded magnetic nanoparticles for breast cancer therapeutics and imaging applications [J]. Int J Nanomedicine , 2012 , 7 : 1761 - 1779 .
CUI J , YU B , ZHAO Y , et al . Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems [J]. Int J Pharm , 2009 , 371 ( 1/2 ): 148 - 155 .
IPAR V S , DSOUZA A , DEVARAJAN P V . Enhancing curcumin oral bioavailability through nanoformulations [J]. Eur J Drug Metab Pharmacokinet , 2019 , 44 ( 4 ): 459 - 480 .
TØNNESEN H H , MÁSSON M , LOFTSSON T . Studies of curcumin and curcuminoids.ⅩⅩⅦ.Cyclodextrin complexation:solubility,chemical and photochemical stability [J]. Int J Pharm , 2002 , 244 ( 1/2 ): 127 - 135 .
JOHN M K , XIE H , BELL E C , et al . Development and pharmacokinetic evaluation of a curcumin co-solvent formulation [J]. Anticancer Res , 2013 , 33 ( 10 ): 4285 - 4291 .
HU L D , SHI Y J , LI J H , et al . Enhancement of oral bioavailability of curcumin by a novel solid dispersion system [J]. AAPS PharmSciTech , 2015 , 16 ( 6 ): 1327 - 1334 .
PETHSOMRIT A , SERMKAEW N , WIWATTANAPATAPEE R . Self-microemulsifying,reconstituted granules for oral administration of curcumin:development and in vitro characterization [J]. Lat Am J Pharm , 2018 , 37 ( 4 ): 740 - 747 .
LIU Y , HUANG P W , HOU X F , et al . Hybrid curcumin-phospholipid complex-near-infrared dye oral drug delivery system to inhibit lung metastasis of breast cancer [J]. Int J Nanomed , 2019 , 14 : 3311 - 3330 .
LI Q P , ZHAI W W , JIANG Q L , et al . Curcumin-piperine mixtures in self-microemulsifying drug delivery system for ulcerative colitis therapy [J]. Int J Pharm , 2015 , 490 ( 1/2 ): 22 - 31 .
THOMAS N , MULLERTZ A , GRAF A , et al . Influence of lipid composition and drug load on the in vitro performance of self-nanoemulsifying drug delivery systems [J]. J Pharm Sci , 2012 , 101 ( 5 ): 1721 - 1731 .
李翔 , 刘亚丽 , 张鹏 , 等 . 姜黄素眼用纳米混悬凝胶剂对大鼠硒性白内障的治疗作用 [J]. 中国实验方剂学杂志 , 2017 , 23 ( 22 ): 9 - 13 .
赖章婷 , 丁海波 , 蒋且英 , 等 . 水飞蓟宾过饱和自微乳给药系统的制备及体外质量评价 [J]. 中草药 , 2019 , 50 ( 17 ): 4091 - 4099 .
陈绪龙 , 梁新丽 , 丁海波 , 等 . 姜黄素过饱和自纳米乳的制备与体外质量评价 [J]. 中国中药杂志 , 2020 , doi: 10.19540/j.cnki.cjcmm.20200523.305 http://dx.doi.org/10.19540/j.cnki.cjcmm.20200523.305 .
VEKILOV P G . Nucleation [J]. Cryst Growth Des , 2010 , 10 ( 12 ): 5007 - 5019 .
ILEVBARE G A , LIU H , EDGAR K J , et al . Maintaining supersaturation in aqueous drug solutions:impact of different polymers on induction times [J]. Cryst Growth Des , 2013 , 13 ( 2 ): 740 - 751 .
RATJI S , CHAVAN R B , SHASTRI N R . Classification of the crystallization tendency of active pharmaceutical ingredients (APIs) and nutraceuticals based on their nucleation and crystal growth behaviour in solution state [J]. Drug Deliv Transl Res , 2020 , 10 ( 1 ): 70 - 82 .
THOMAS N , HOLM R , MÜLLERTZ A , et al . In vitro and in vivo performance of novel supersaturated self-nanoemulsifying drug delivery systems (super-SNEDDS) [J]. J Control Release , 2012 , 160 ( 1 ): 25 - 32 .
0
浏览量
22
下载量
3
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621